Yuming Zhong

Ganzhou People's Hospital

Papers

1

Total Citations

6

H-Index

1

About

Dr. Yuming Zhong is a leading urologic oncologist whose research centers on advancing minimally invasive surgical techniques for renal cell carcinoma (RCC). His major contributions lie in refining robotic-assisted approaches to maximize kidney preservation while ensuring oncological safety. In a landmark 2023 study, Dr. Zhong compared robotic-assisted tumor enucleation (RATE) with robotic-assisted partial nephrectomy (RAPN) for intermediate and high complexity RCC, drawing on a robust single-institution cohort of 359 patients. This work, which has already garnered 6 citations, provides critical evidence that RATE may offer superior perioperative outcomes without compromising cancer control—a finding that directly informs surgical decision-making for complex cases. Dr. Zhong’s research is distinguished by its focus on high-complexity tumors, where the balance between nephron-sparing and complete resection is most challenging. His findings are shaping best practices in robotic urologic surgery, offering patients safer, more effective treatment options. For students and researchers, Dr. Zhong’s work exemplifies how rigorous comparative effectiveness research can translate into tangible improvements in surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
6 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Ganzhou People's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago